Clin Exp Otorhinolaryngol.  2009 Dec;2(4):181-185. 10.3342/ceo.2009.2.4.181.

Initial Adherence to Autotitrating Positive Airway Pressure Therapy: Influence of Upper Airway Narrowing

• So YK
• Dhong HJ
• Kim HY
• Chung SK
• Jang JY

• KMID: 1466495
• DOI: http://doi.org/10.3342/ceo.2009.2.4.181

Abstract

OBJECTIVES
There is still debate concerning the reason for the high initial failure rate of positive airway pressure (PAP) treatment. The objective of this study is to investigate the factors of the initial adherence to PAP, with an emphasis on the role of upper airway narrowing. METHODS: The patients were divided into two groups according to the continuation of therapy within the first three months of treatment. The demographic and polysomnographic findings, the minimal nasal cross sectional area (MCA), the degree of palatine tonsilar hypertrophy (PTH) and the modified Mallampati grade of the oropharynx inlet (Orophx) were compared between the study groups. RESULTS: Among 36 patients, 23 continued the auto-adjusting positive airway pressure (APAP) therapy (the adherent group) and 13 discontinued APAP within three months (the non-adherent group). The apnea-hypopnea index (AHI) was significantly higher in the adherent group than in the non-adherent group (P<0.001). The AHI distributions of the two groups are extremely different. Thirteen of the 23 patients in the adherent group had an AHI of more than 60/hr, while none of the patients in the non-adherent group had an AHI of more than 60/hr. In the patients with an AHI from 15 to 60/hr, the MCA at the wide side of the nasal cavity and the sum of the MCAs of both sides were significantly larger in the adherent group than those values in the non-adherent group (P=0.004). The PTH and the Orophx were not significantly different between the two groups. CONCLUSION: AHI is a definite significant factor of adherence to APAP therapy. The dimension of the nasal cavity has an influence on initial APAP adherence in the patients who have a not too high level of AHI.

Keyword

Continuous positive airway pressure; Compliance; Adherence; Upper airway; Nasal cavity

MeSH Terms

Acetaminophen
Bays
Compliance
Continuous Positive Airway Pressure
Humans
Hypertrophy
Nasal Cavity
Oropharynx
Acetaminophen

Reference

1. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society: official statement adopted March 1944. Am J Respir Crit Care Med. 1994; 12. 150(6 Pt 1):1738–1745. PMID: 7952642.

2. Kim JH, Kwon MS, Song HM, Lee BJ, Jang YJ, Chung YS. Compliance with positive airway pressure treatment for obstructive sleep apnea. Clin Exp Otorhinolaryngol. 2009; 6. 2(2):90–96. PMID: 19565034.

3. Rolfe I, Olson LG, Saunders NA. Long-term acceptance of continuous positive airway pressure in obstructive sleep apnea. Am Rev Respir Dis. 1991; 11. 144(5):1130–1133. PMID: 1952444.

4. Kim HY, Min JY, Cho DY, Chung SK, Dhong HJ. Influence of upper airway narrowing on the effective continuous positive airway pressure level. Laryngoscope. 2007; 1. 117(1):82–85. PMID: 17202935.

5. Sugiura T, Noda A, Nakata S, Yasuda Y, Soga T, Miyata S, et al. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration. 2007; 74(1):56–60. PMID: 16299414.

6. Friedman M, Tanyeri H, La Rosa M, Landsberg R, Vaidyanathan K, Pieri S, et al. Clinical predictors of obstructive sleep apnea. Laryngoscope. 1999; 12. 109(12):1901–1907. PMID: 10591345.

7. Pelletier-Fleury N, Rakotonanahary D, Fleury B. The age and other factors in the evaluation of compliance with nasal continuous positive airway pressure for obstructive sleep apnea syndrome: a Cox's proportional hazard analysis. Sleep Med. 2001; 5. 2(3):225–232. PMID: 11311685.

8. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999; 4. 159(4 Pt 1):1108–1114. PMID: 10194153.

9. Grunstein RR. Sleep-related breathing disorders. 5: Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax. 1995; 10. 50(10):1106–1113. PMID: 7491563.

10. Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med. 2000; 2. 94(2):145–149. PMID: 10714420.

11. Friedman M, Tanyeri H, Lim JW, Landsberg R, Vaidyanathan K, Caldarelli D. Effect of improved nasal breathing on obstructive sleep apnea. Otolaryngol Head Neck Surg. 2000; 1. 122(1):71–74. PMID: 10629486.

12. Nowak C, Bourgin P, Portier F, Genty E, Escourrou P, Bobin S. Nasal obstruction and compliance to nasal positive airway pressure. Ann Otolaryngol Chir Cervicofac. 2003; 6. 120(3):161–166. PMID: 12843985.

13. Morris LG, Burschtin O, Lebowitz RA, Jacobs JB, Lee KC. Nasal obstruction and sleep-disordered breathing: a study using acoustic rhinometry. Am J Rhinol. 2005; Jan–Feb. 19(1):33–39. PMID: 15794072.

14. Hollandt JH, Mahlerwein M. Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). Sleep Breath. 2003; 6. 7(2):87–94. PMID: 12861488.

15. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep. 1992; 12. 15(6 Suppl):S42–S46. PMID: 1470808.

16. Meurice JC, Dore P, Paquereau J, Neau JP, Ingrand P, Chavagnat JJ, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest. 1994; 2. 105(2):429–433. PMID: 8306741.

17. Morris LG, Setlur J, Burschtin OE, Steward DL, Jacobs JB, Lee KC. Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Am J Rhinol. 2006; Mar–Apr. 20(2):133–137. PMID: 16686374.

18. Schechter GL, Ware JC, Perlstrom J, McBrayer RH. Nasal patency and the effectiveness of nasal continuous positive air pressure in obstructive sleep apnea. Otolaryngol Head Neck Surg. 1998; 5. 118(5):643–647. PMID: 9591863.

19. Lofaso F, Coste A, d'Ortho MP, Zerah-Lancner F, Delclaux C, Goldenberg F, et al. Nasal obstruction as a risk factor for sleep apnoea syndrome. Eur Respir J. 2000; 10. 16(4):639–643. PMID: 11106205.

20. Yetkin O, Kunter E, Gunen H. CPAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath. 2008; 11. 12(4):365–367. PMID: 18481129.

21. Collard P, Pieters T, Aubert G, Delguste P, Rodenstein DO. Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev. 1997; 11. 1(1):33–44. PMID: 15310522.